Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 83

2.

C-reactive protein promotes vascular endothelial dysfunction partly via activating adipose tissue inflammation in hyperlipidemic rabbits.

Chen Y, Wang X, Mai J, Zhao X, Liang Y, Gu M, Chen Z, Nie R, Wang J.

Int J Cardiol. 2013 Oct 3;168(3):2397-403. doi: 10.1016/j.ijcard.2013.01.158. Epub 2013 Feb 27.

PMID:
23452887
3.

5-lipoxygenase deficiency reduces hepatic inflammation and tumor necrosis factor alpha-induced hepatocyte damage in hyperlipidemia-prone ApoE-null mice.

Martínez-Clemente M, Ferré N, González-Périz A, López-Parra M, Horrillo R, Titos E, Morán-Salvador E, Miquel R, Arroyo V, Funk CD, Clària J.

Hepatology. 2010 Mar;51(3):817-27. doi: 10.1002/hep.23463.

PMID:
20112424
4.

Suppression of inflammatory response and endothelial nitric oxide synthase downregulation in hyperlipidaemic C57BL/6J mice by eugenosedin-A.

Shen KP, Lin HL, Chang WT, An LM, Chen IJ, Wu BN.

J Pharm Pharmacol. 2011 Jun;63(6):860-8. doi: 10.1111/j.2042-7158.2011.01285.x. Epub 2011 May 3.

PMID:
21585385
5.
6.

Atorvastatin inhibits the 5-lipoxygenase pathway and expression of CCL3 to alleviate atherosclerotic lesions in atherosclerotic ApoE knockout mice.

Yang LX, Heng XH, Guo RW, Si YK, Qi F, Zhou XB.

J Cardiovasc Pharmacol. 2013 Aug;62(2):205-11. doi: 10.1097/FJC.0b013e3182967fc0.

PMID:
23615158
7.

Effects of atorvastatin, simvastatin, and fenofibrate therapy on monocyte chemoattractant protein-1 secretion in patients with hyperlipidemia.

Kowalski J, Okopień B, Madej A, Zieliński M, Belowski D, Kalina Z, Herman ZS.

Eur J Clin Pharmacol. 2003 Jul;59(3):189-93. Epub 2003 May 17.

PMID:
12756509
8.

Synergistic effects of colchicine combined with atorvastatin in rats with hyperlipidemia.

Huang C, Cen C, Wang C, Zhan H, Ding X.

Lipids Health Dis. 2014 Apr 17;13:67. doi: 10.1186/1476-511X-13-67.

10.

Atorvastatin enhances interleukin-10 levels and improves cardiac function in rats after acute myocardial infarction.

Stumpf C, Petzi S, Seybold K, Wasmeier G, Arnold M, Raaz D, Yilmaz A, Daniel WG, Garlichs CD.

Clin Sci (Lond). 2009 Jan;116(1):45-52. doi: 10.1042/CS20080042.

PMID:
18459941
11.

Atorvastatin improves endothelial function in renal-transplant recipients.

Asberg A, Hartmann A, Fjeldså E, Holdaas H.

Nephrol Dial Transplant. 2001 Sep;16(9):1920-4.

PMID:
11522880
12.

[The effect of atorvastatin on the expression of CD55, CD59 in patients with hyperlipidemia].

Liu YM, He JC, Yang JG, Liu YY, Yan X, Zhao L, Ma XW, Shang DY, Qiao CD, Li WX, Wang JY.

Zhonghua Xin Xue Guan Bing Za Zhi. 2005 Dec;33(12):1075-9. Chinese.

PMID:
16563273
13.

Anti-inflammatory effect of atorvastatin ameliorates insulin resistance in monosodium glutamate-treated obese mice.

Furuya DT, Poletto AC, Favaro RR, Martins JO, Zorn TM, Machado UF.

Metabolism. 2010 Mar;59(3):395-9. doi: 10.1016/j.metabol.2009.08.011. Epub 2009 Oct 2.

PMID:
19800637
14.

Atorvastatin decreases C-reactive protein-induced inflammatory response in pulmonary artery smooth muscle cells by inhibiting nuclear factor-kappaB pathway.

Li J, Li JJ, He JG, Nan JL, Guo YL, Xiong CM.

Cardiovasc Ther. 2010 Spring;28(1):8-14. doi: 10.1111/j.1755-5922.2009.00103.x.

PMID:
20074254
15.

Atorvastatin improves insulin sensitivity in mice with obesity induced by monosodium glutamate.

Zhang N, Huan Y, Huang H, Song GM, Sun SJ, Shen ZF.

Acta Pharmacol Sin. 2010 Jan;31(1):35-42. doi: 10.1038/aps.2009.176. Epub 2009 Dec 21.

16.

Hyperlipidemia modifies innate immune responses to lipopolysaccharide via the TLR-NF-κB signaling pathway.

Chen S, Lin G, Lei L, You X, Wu C, Xu W, Huang M, Luo L, Wang Z, Li Y, Zhao X, Yan F.

Inflammation. 2013 Aug;36(4):968-76. doi: 10.1007/s10753-013-9628-9.

PMID:
23504260
17.

Evidence for activation of inflammatory lipoxygenase pathways in visceral adipose tissue of obese Zucker rats.

Chakrabarti SK, Wen Y, Dobrian AD, Cole BK, Ma Q, Pei H, Williams MD, Bevard MH, Vandenhoff GE, Keller SR, Gu J, Nadler JL.

Am J Physiol Endocrinol Metab. 2011 Jan;300(1):E175-87. doi: 10.1152/ajpendo.00203.2010. Epub 2010 Oct 26.

18.

5-lipoxygenase activating protein signals adipose tissue inflammation and lipid dysfunction in experimental obesity.

Horrillo R, González-Périz A, Martínez-Clemente M, López-Parra M, Ferré N, Titos E, Morán-Salvador E, Deulofeu R, Arroyo V, Clària J.

J Immunol. 2010 Apr 1;184(7):3978-87. doi: 10.4049/jimmunol.0901355. Epub 2010 Mar 5.

19.

Atorvastatin reduces plasminogen activator inhibitor-1 expression in adipose tissue of atherosclerotic rabbits.

Li JQ, Zhao SP, Li QZ, Cai YC, Wu LR, Fang Y, Li P.

Clin Chim Acta. 2006 Aug;370(1-2):57-62. Epub 2006 Feb 28.

PMID:
16507303
20.

Lack of interleukin-1 receptor I (IL-1RI) protects mice from high-fat diet-induced adipose tissue inflammation coincident with improved glucose homeostasis.

McGillicuddy FC, Harford KA, Reynolds CM, Oliver E, Claessens M, Mills KH, Roche HM.

Diabetes. 2011 Jun;60(6):1688-98. doi: 10.2337/db10-1278. Epub 2011 Apr 22.

Supplemental Content

Support Center